MICROSHARE, INC.

Profile

Company Names

MICROSHARE, INC.
POINT.IO, LLC

Addresses

1635 MARKET STREET, SUITE 1600, PHILADELPHIA, PA 19107

1900 MARKET STREET, 8TH FLOOR, PHILADELPHIA, PA 19103

489 DEVON PARK DRIVE, SUITE 311, WAYNE, PA 19087

Phone Numbers

(267) 225-4841
(610)994-9660
(610) 994-9660

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$28,112,288.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2024-02-09 
$5,864,310.00 
$11,000,000.00 
$5,135,690.00 
Equity 
4
2022-09-12 
$18,089,901.00 
$18,089,901.00 
$0.00 
Equity 
3
2016-10-05 
$2,358,077.00 
$4,921,897.00 
$2,563,820.00 
Equity 
2
2013-10-02 
$750,000.00 
$4,000,000.00 
$3,250,000.00 
Equity 
1
2013-02-01 
$1,050,000.00 
$1,500,000.00 
$450,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PHIL 
 
ADAMS 
EXECUTIVE OFFICER
THOMAS 
 
JACKSON 
EXECUTIVE OFFICER
TOM 
 
JACKSON 
EXECUTIVE OFFICER
MICHAEL 
 
MURPHY 
EXECUTIVE OFFICER
GLEICHEN RESOURCES LTD.   |  NEXUS ENERGYHOMES, INC.   |  TMG ENERGY CORP   |  DIAMOND FOODS INC   |  TOREX GOLD RESOURCES INC.   |  3D VISION SYSTEMS LLC   |  NATIONAL GENERAL HOLDINGS CORP.   |  HOLY MOUNTAIN BREWING CO   |  AMERICAN HOTEL INCOME PROPERTIES REIT INC.   |  STACKIQ, INC.   |  KINEX PHARMACEUTICALS, INC.   |  DISTRIBU.TD, INC.   |  TRANSEASTERN POWER TRUST   |  SUN CLINICAL LABORATORY, LLC - SERIES 4   |  SUN CLINICAL LABORATORY, LLC - SERIES 3   |  SUN CLINICAL LABORATORY, LLC - SERIES 1   |  SUN CLINICAL LABORATORY, LLC - SERIES 7   |  SUN CLINICAL LABORATORY, LLC - SERIES 5   |  SUN CLINICAL LABORATORY, LLC - SERIES 10   |  SUN CLINICAL LABORATORY, LLC - SERIES 8   |  SUN CLINICAL LABORATORY, LLC - SERIES 9   |  SUN CLINICAL LABORATORY, LLC - SERIES 14   |  PROCTORFREE, INC.   |  SUN CLINICAL LABORATORY, LLC - SERIES 15   |  ROSECLIFF VENTURE PARTNERS, LP   |  AHTOVATION, INC.   |  ADVANTAGE ADVISERS XANTHUS FUND, L.L.C.   |  AKONNI BIOSYSTEMS INC   |  SUN CLINICAL LABORATORY, LLC - SERIES 29   |  ALTERNATE HEALTH CORP.   |  ROSECLIFF VENTURE PARTNERS II, LP   |  ASSABET VALLEY BANCORP   |  AMPLE HILLS HOLDINGS, INC.   |  POST.BID.SHIP., INC.   |  PROPHET ADVANTAGE PARTNERS LP   |  ETHOS GOLD CORP.   |  TENEO PARTNERS, LP   |  ROSECLIFF CREDIT OPPORTUNITY FUND I, L.P.   |  TORTOISE, INC.   |  QUISITIVE TECHNOLOGY SOLUTIONS, INC.   |  PROSPECTOR METALS CORP.   |  BATTERY METALS STREAMING CORP.   |  ANTHEM SPORTS + ENTERTAINMENT INC.   |  MICROSHARE, INC.   |  ANOKIWAVE, INC.   |  ROSECLIFF FRONTIER TECHNOLOGIES FUND I, L.P.   |  AQUILA HARTLAND HOLDINGS, LLC   |  BOOSTLY, INC.   |  SOUTH PACIFIC METALS CORP.   |  ARA LABS INC.   |  NEXT GENERATION SPV 1 LLC   |  NEXT GENERATION SPV 2 LLC   |  NEXT GENERATION SPV 3 LLC   |  WPSL PRO, LLC   |  ROSECLIFF NEXT GENERATION LLC - SERIES RSAI ACCESSS-1   |  ROSECLIFF NEXT GENERATION LLC - SERIES P ACCESS   |  ROSECLIFF NEXT GENERATION LLC - SERIES CBIO ACCESS -1   |  ROSECLIFF NEXT GENERATION LLC - SERIES PVTR ACCESS
KEITH 
 
ORRIS 
DIRECTOR
TIM 
 
PANAGOS 
EXECUTIVE OFFICER
TOM 
 
PANAGOS 
EXECUTIVE OFFICER
CHARLES 
 
PAUMELLE 
EXECUTIVE OFFICER
RONALD 
 
ROCK 
EXECUTIVE OFFICER, DIRECTOR
ROCK 
 
RONALD 
EXECUTIVE OFFICER, DIRECTOR
ARTHUR 
 
ROSENZWEIG 
DIRECTOR
MICHAEL 
 
SANCHEZ 
DIRECTOR
ANDREW 
 
SCHWABE 
DIRECTOR
TIMOTHY 
 
WALLACE 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-02-09 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-12 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-10-05 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-02 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-02-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#